FABP2 and myalgic encephalomeyelitis/chronic fatigue syndrome: In the case-control analysis (Figure 2), serum levels of FABP-2 were significantly higher in ME/CFS patients than in controls (F1,72 = 24.022, p < 0.001, ηp2 = 0.255).